Cardiology Flashcards

1
Q

Characteristics of aortic valve regurgitation

A

Volume overload of LV
Dilated aota due to high stroke volume
increased systolic BP/decreased diastolic BP = wide pulse pressure + bounding pulses
Murmur: early diastolic blowing, LSB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Characteristics of mitral valve regurgitation

A

Volume overload of LA/LV
Murmur: systolic blowing, apex; diastolic at apex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Characteristics of tricuspid valve regurgitation

A

Volume overload of RA/RV
Murmur: can be normal in newborn with elevated PVR; systolic blowing at LLSB, diastolic rumble at LSB
If severe, enlarged pulsatile liver and distended neck veins (blood backing up into IVC/SVC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hypertrophic cardiomyopathy

A

Pompe, Hurler, Noonan
Infant of a diabetic mother, postnatal steroids- transient
Variable ventricular hypertrophy with increased inotropic function
Diastolic dysfunction is a prominent feature

Digoxin contraindicated: increases contractility which may lead to increased obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dopamine acts of which receptors at which doses?

A

2-4: dopaminergic, renal vasodilation and splanchnic vessels
2-6: beta 1/2 chronotropy (HR) and contractility
6-10: alpha 1 vasoconstriction
10-20: alpha 1 increased PVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Congestive or dilated cardiomyopathy

A

Increased risk of abnormal myocardium, abnormal coronary perfusion or following arrhythmia
Decreased ventricular inotropic function during systole associated wtih dilatation of left atria and left ventricle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Restrictive cardiomyopathy

A

Least common
Abnormal ventricular filling during diastole associated with stiff ventricles
Normal initial systolic function
Atrial dilatation out of proportion to ventricular dilatation (stiff walls of RV/LV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where does norepinephrine work?

A

Endogenous catecholamine
Increases SVR and CO by alpha 1, beta 1 & 2
Constricts systemic vascular&raquo_space; pulmonary vascular
risk of hypocalcemia, hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of action of dobutamine

A

Acts directly in alpha and beta receptors without release of norepi

NO CHANGE IN SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hydrocortisone

A

Hyperglycemia
Osteopenia
Inhibits immune function and somatic growth
Associated with SIP if concurrnet indomethacin

Aid in hypotension by decreasing breakdown of catecholamines, increase calcium in myocardial cells and upregulating adrenergic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pericardial effusions

A

Etiology: pericarditis, severe anemia with CHF, post-cardiac surgery, leak from central venous catheter

pulses paradoxus
pericardial tamponade, tachycardia, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

EKG finding in ALCAPA

A

deep Q waves in I, aVL, V4, V5, V6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cardiac rhabdomyoma

A

MC primary cardiac tumor in neonates
usually multiple
EKG= delta wave (predisposed to SVT, WPW)
increased risk if tubeous sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HLHS

A

RV + tricuspid valve represent systemic ventricle + AV valve
Paliation with Norwood procedure
Mutations: HAND1, NOTCH1
Recurrence HLHS sibling 8%
Recurrence of any congenital 22%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Normal neonatal EKG findings

A

Normal QRS measured in V5: 20-80msec
Axis term: +55 to +200
Axis preterm: +65-+174

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Predominant myocardial substrate prenatally and postnatally

A

Prenatally: glucose, lactate
Postnatally: fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Characteristics of asplenia

A
  1. Sequence of bilateral RIGHT-sidedness: 2 right lungs, midline liver, 2 gallbaldders
  2. Always severe cardiac malformations: aorta and IVC juxtaposed (100%), TAPVS (90%), TGA/bilateral SVD/PS/PA (75%)
  3. Howell-Jolly bodies, Heinz bodies
  4. Increased risk of infection: Strep pneumoniae
  5. Cyanosis
  6. Poor prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Characteristics of polysplenia

A
  1. Sequence of bilateral LEFT-sidedness: 2 left lungs, midline liver, increased incidence of biliary atresia
  2. Less severe cardiac malformation: azygous return of IVC/TAPVR (70%), bilateral SVC (50%), AVC (40%)
  3. Cyanosis
  4. Poor prognosis: better than asplenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Boot shaped heart

A

TOF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Snowman

A

TAPVR- supracardiac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Egg on a string

A

D-TGA

REVERSE DIFFERENTIAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Extremely large heart

A

Ebstein’s anomaly

LITHIUM!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Small heart with increased pulmonary blood flow

A

Obstructive TAPVR (infradiaphragmatic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Conduction pathway

A
  1. SA node –> contraction of both atria (P WAVE)
  2. Impulse hits AV node –> delay allows ventricles to fill (PR SEGMENT) (protects from atrial tachycardias)
  3. Impulse rapidly spreads down bundle of His to bundle branches and Purkinje fibers to myocardia cells–> ventricular contraction, atrial repolarization (QRS WAVE- Q= septal depolarization)
  4. Ventricles repolarize –> ventricular relaxation (ST SEGMENT, T WAVE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Fetal SVT

A
  1. More common than atrial flutter
  2. HR 240-310, 1:1 AV association
  3. ~28-32 weeks gestation
  4. hydrops may develop- depends on duration, degree of immaturity

Treatment:
1st line –> Digoxin (inhibits Na/K/ATPase- slows conduction, prolong AV node refractory period)- IV to mom
2nd line if FETUS LESS ILL–> Flecainide- more effective but 7-15% mortality; Sotolol- mortality rate higher
2nd line if FETUS ILL –> amiodarone (K channel blocker- incr refractory period): give 1-2 days after dig started, give orally

Post-natal management:
Monitor for complications of meds:
1. hyperbilirubinemia
2. anemia from bone marrow suppression
3. greater risk of NEC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Fetal atrial flutter

A
  1. Less common
  2. HR 425-500, VARIABLE AV contraction
  3. Irregular
  4. Majority with underlying reentrant tachycardia
  5. Later in pregnancy than SVT
  6. Hydrops less common, if CHD, worse prognosis than SVT

Treatment:
1. Digoxin- IV to mom
2. Sotalol (K channel blocker with beta blocker effect): tx of choice for refractory atrial flutter
Amiodarone NOT EFFECTIVE

Post-natal management:
Monitor for complications of meds:
1. hyperbilirubinemia
2. anemia from bone marrow suppression
3. greater risk of NEC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Fetal ventricular tachycardia

A

Associated with:
1. complete heart block
2. long QT syndrome
3. myocarditis

Often combo of bradycardia or AV block and tachycardia

HR 210-260
Difficult to treat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Fetal sinus tachycardia

A

setting of maternal thyrotoxicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Fetal AV block

A

AV block and fetus with NORMAL cardiac anatomy and EXPOSURE to maternal SSA/SSB Abs
1. positive Abs = more likely to need pacing at birth, develop cardiomyopathy, more severe form of block
2. Majority pregnancy women are asymptomatic
3. Fetus presents with 2nd or 3rd degree AV block

AV block and fetus with ABNORMAL cardiac anatomy and WITHOUT maternal antibodies
1. poorer prognosis
2. higher risk for hydrops and severe congestive heart failure
3. congential heart defects: atrial isomerism with asplenia or polysplenia, L-TGA, AV septal defect
4. usually require pacing in neonatal period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Fetal ectopy- what is baby at risk for?

A

SVT in first month of age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

PAC

A
  1. common in newborns
  2. originates in atrium, leads to contraction before sinus node
  3. early p wave- different axis/morphology
  4. typically benign

Associated with:
1. hypokalemia
2. hypoglycemia
3. hypercalcemia
4. drugs
5. hypoxemia
6. cental line irritation of right atrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

PVC

A
  1. Early beat with abnormal and prolonged QRS, ST slope away from QRS, no P wave
  2. originates below AV node and bundle of His
  3. Unifocal or multifocal

Asymptomatic with isolated PVCs, normal cardiac anatomy- no treatment

Causes:
1. digoxin toxicity
2. infection
3. Ca/K/Mg abnormalities
4. hypoxemia
5. acidosis
6. CHD
7. excess aminophylline/caffeine
8. myocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Atrial flutter

A

SAWTOOTH PATTERN: II, III, avF, V1
rate 300-500 bpm
starts and ends suddenly

  1. difficult to distinguish from SVT- ice/adenosine can reveal flutter at slower rate
  2. Stable: block atrial (digoxin) and ventricular rate
  3. Unstable: synchronized cardioversion, pacing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Types of SVT

A

Orthodromic tachycardia
1. p wave AFTER QRS, narrow QRS, +/- WPW
2. MC form in neonate
3. Pathway: down AV node, up accessory/orthodromic pathway (why p wave after QRS)
4. responds to vagal/adenosine

Antidromic tachycardia
1. p wave axis superior, invereted in II/avF, wide QRS with WPW
2. less common
3. Pathway: down accessory/antidromic, returns back to atria backwards
4. respons to vagal/adenosine

AV nodal re-entry tachycardia
1. p wave not visible- atria/ventricle depolarize AT SAME TIME
2. less common
3. slow and fast pathways are both present
4. responds to vagal/adenosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

SVT

A

Increased risk
1. CHD: ebsteins, L-TGA
2. medications: caffeine, epi
3. cardiomyopathy
4. myocarditis
5. cardiac tumors
6. fever
7. hyperthyroidism

NARROW COMPLEX QRS, p waves difficult to identify
Rate: 220-330- litte variation, begins and ends abruptly

Management:
1. Unstable: synchronized cardioversion (0.5-2J/kg)
2. Stable: vagal maneuvers, adenosine IV (transiently blocks AV node)
3. after SVT resolved, repeat EKG and determine if underlying rhythm abnormal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

WPW

a type of SVT

A
  1. Prolonged QRS
  2. Shortened PR interval
  3. Initial slurring of QRS= DELTA WAVE

Secondary to electrical pathway between A and V, bypassing AV node, associated with SVT
Ebsteins, L-TGA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How does milrinone work?

A
  1. phosphodiesterase 3 inhibitor (ihibits cAMP breakdown–> incr intracellular Ca–> incr contracility–> vascular smooth muscle relaxes–> vasodilation, dec afterload)
  2. inotrope: NOT dependent on neurotransmitter stores/receptors
  3. decreases SVR
  4. some pulmonary vasodilation
  5. R heart failure or weaning from bypass

may induce thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Digoxin

A
  1. inhibits Na/K/ATPase pump in cardiac myocytes–> incr Ca influx –> incr contractility + decr afterload
  2. decreases SVR
  3. Use: CHF
  4. Anti-arrhythmic: decr AV conduction
  5. Toxicity: GI sx, decr HR, prolonged PR interval, AV block
    monitor K+ and Ca levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Dobutamine

A

B1&raquo_space; B2, little alpha activity

  1. chronotrope and inotrope –> synthetic catecholamine (incr cAMP levels)
  2. may decr SVR
  3. Use: Cardiogenic shock, myocardial dysfunction (no incr afterload) –> improves coronary blood flow and myocardial oxygen delivery
    no effect on renal blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Dopamine

A
  1. endogenous catecholamine, precursor to epi and NE, alpha and beta - more peripherally
  2. inhibits Na/K/ATPase and Na/H+ pump
  3. effect: releases endogenous NE–> decr effectiveness with prolonged use
  4. ++chronotrope, + inotrope
  5. incr SVR –> effect is dose dependent
  6. septic shock!

low dose= dilates renal vasculature

inhibits thyrotropin release–> inaccurate thyroid screen results

if extravasation, use phentolamine (alpha agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Epinephrine

A
  1. MOST POTENT vasopressor, endogenous catecholamine
  2. Beta 1 and 2 at lower doses (<0.3), alpha at higher doses
  3. ++chronotrope, +inotrope
  4. SVR effect is dose-dependent: dilation at lower doses, constriction at high doses
  5. side effects: hypokalemia, local tissue ischemia, renal vascular ischemia, severe hypertension

higher dose= incr diastolic pressure, better coronary artery perfusion due to increased afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Infections associated with myocarditis

A

Parvo B19 and Coxsackie
Rubella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What congentical heart issue can maternal aspirin use cause?

A

Pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What congenital heart issue can maternal use of SSRI cause?

A

Pulmonary hypertension

45
Q

How does maternal lupus increase risk for congenital heart block?

A

Maternal anti-Ro (SS-A)/La (SS-B) autoantibodies = IgG class = can cross placenta –> deposit on fetal myocardium–> disrupt calcium metabolism–> apoptosis of AV cells –> conduction abnormalities–> inflammation –> scar tissue and fibrosis, AV node calcification

risk indepedent of severity of maternal illness
- can be first sign of maternal Lupus
- once complete heart block established, it is permanent- AV node replaced by scar tissue

46
Q

Narrow pulse pressure

A

pericardial tamponade
aortic stenosis
intravascular depletion

47
Q

Widened pulse pressure

A

PDA (L to R)
Truncus arteriosus
Thyrotoxicosis
AV fistula
Aortic regurgitation

48
Q

Vein of Galen aneurysm

A
  1. 40-60% present during neonatal period
  2. persistent embryologic prosencephalic vein of Markowski (anterior to vein of Galen)
  3. Neuro effects assoc with ischemic infarction, hemorrhage, and mass effect on brain structures
  4. Develops CHF: compensate for large CO that flows through aneurysm (95% present with CHF)
  5. Hydrocephalus and intracranial hemorrhage

Physical findings:
1. bounding carotid pulses –> bobbing of the head
2. cranial bruit
3. signs of CHF: hepatomegaly, murmur
4. thrombocytopenia, DIC: consumption within aneurysm

49
Q

Causes for Neonatal Hypertension

A

H: Heart disease (coarct, PDA)
Y: yet undetermined
P: Pulmonary disease (BPD)
E: Endocrine disorder (CAH, adrenal hemorrhage, hyperaldosteronism, hyperthyroidism, Cushing)
R: Renal disease (thrombus, polycystic/dysplasitc/hypoplastic kidney, obstructive uropathy, ATN)
T: TPN (high calcium/salt)
E: ECMO
N: Neoplasm (Wilms, neuroblastoma, pheochromocytoma)
S: Surgery (abdominal wall defect repair)
I: Intoxication (dexamethasone, xanthines, adrenergic drugs, phenylephrine eye drops, cocaine)
O: Opioid withdrawal
N: Neurologic cause (seizures, pain, ICH, intracranial hypertension

50
Q

Congenital cardiac condition most threatening to pregnant women and their fetuses

A

Eisenmenger syndrome- pulmonary hypertension

51
Q

Factors that promote closure of the PDA

A

Functional closure
1. increase in PaO2
2. Decrease in blood pressure within the ductus arteriosus (postnatal fall in pulmonary vascular resistance)
3. Decreased concentration of PGE2 (decrease in placental PG production, increase in PG metabolism in lungs)
4. Decreased number of ductal arteriosus PGE2 receptors

Structural closure:
1. oxygen-mediated constriction of the PDA results in zone of tissue hypoxia in the ductal media–> signal for irreversible anatomic closure
2. Hypoxia induced growth factors (VEGF, TGF-beta) initiate ductal remodeling

with greater degrees of prematurity, ductal wall is more permeable to oxygen because it is thinner–> continued oxygen exposure doesnt allow for media hypoxia, cell death, remodeling which needs to occur for anatomic closure

52
Q

iNO is contraindicated in which cardiac lesions:

A

HLHS
critical aortic stenosis
interupted aortic arch

lesions dependent on R to L shunting through PDA- need to keep pulmonary pressures high

53
Q

Medication that has the most vasodilatory effect on PDA

A

Furosemide
stimulation of prostaglandin synthesis

54
Q

Explain oliguria that occurs with indomethacin treatment for PDA

A
  1. Indomethacin blocks prostaglandin E production, prostaglandin E inhibits vasopressin/renin-angiotensin induced fluid retention -> without prostaglandin, fluid retention and oliguria occurs
  2. Indomethacin redistributes renal blood flow away from mature nephrons of inner cortex to immature nephrons of outer cortex
55
Q

Effect of hemoglobin concentration and oxygen tension on oxygen content

A
56
Q

Changes in afterload on the ventricular function curve

A
57
Q

Changes in ventricular function with changes in inotropy

A
58
Q

Pathogensis of meconium aspiration syndrome

A
59
Q

Mainstays of therapy for meconium aspiration

A

oxygen
iNO
mechanical ventilation

insufficient evidence for steroid use, routine/prolonged Abx, amnioinfusion

60
Q

What diagnosis has the highest mortality on ECMO?

A

CDH

CDH ECMO survival ~50%

no evidence that surf or antenatal steroids improve outcomes

61
Q

Dual hit hypothesis for CDH

A
  1. Bilateral lung hypoplasia during organogenesis
  2. Ipsilateral lung compression by abdominal herniation

overall CDH survival 70-90%

62
Q

long term complications of CDH

A

CLD
PHTN
GE reflux
Feeding difficulties
scoliosis
developmental delay
hearing loss

63
Q

Most common indication for neonatal ECMO

A

respiratory failure

64
Q

sildenifil

A

phosphodiesterase 5

S looks like 5

65
Q

Milrinone

A

phosphodiesterase 3
M looks like 3

66
Q

Qp/Qs >1

A

L to R shunt
PDA

67
Q

Qp/Qs<1

A

R to L shunt
PPHN

68
Q

cardiac pressure volume loop

A
69
Q

changes on pressure/volume loop due to changes in contractility/inotropy

A
70
Q

changes on pressure/volume loop due to changes in afterload

A
71
Q

changes on pressure/volume loop due to changes in preload

A
72
Q
A

parts of EKG

73
Q

sinus rhythm

A
74
Q
A

PAC

atrial myocyte initiates a beat between impulses coming from the sinus node

Workup:
- ensure normal electrolytes
- remove PICC/UVC from atrium
- monitor
- consider echo if persists

look at the T wave immediately before unusual complex- altered= PAC

75
Q
A

PVC
~20% premature, ~4% term

Reasuring features:
- single morphology
- isolated beats
- suppresses when HR increases

compensatory pause after the PVC beat

76
Q
A

sinus bradycardia

may be benign- transient bradycardia and QTc prolongation < 470ms may occur after stressful delivery

channelopathies: congenital long QT syndrome

77
Q
A

Neonatal long QT syndrome = cardiac channelopathy assoc with neonatal bradycartion

QTc up to 0.49 may be normal in less than 6 mo

78
Q

Causes of prolonged QTc

A
  • hypocalcemia
  • hypokalemia
  • hypomagnesemia
  • CNS abnormalities
  • myocarditis
  • channelopathy

3 genes = 75%
1. KCNQ1=LQT1
2. KCNH2=LQT2
3. SCN5A=LQT3

79
Q

prolonged QT and 2:1 AV heart block is a risk factor for what?

A

Torsades de pointes

80
Q
A

First degree heart block

81
Q
A

2nd degree- Mobitz 1/Wenckebach

BENIGN
- seen with medications or high vagal states

82
Q
A

2nd degree/Mobitz II

PATHOLOGIC
- block is below AV node
- may progress to complete heart block
- may require pacemaker
- evaluate for: LQTS (when rhythm 2:1), myocarditis

83
Q
A

Complete heart block

Maternal SLE- may be first sign of disease in mother
SSA/Ra, SSB/LA- cross placenta and deposit on AV node
Associated with L-TGA

84
Q

Most likely type of tachyarrhythmia in term newborn

A

WPW
AV reentry tachycardia (AVRT)

atrial impulse enters through accessory pathway- dont see pause in electrical activity = DELTA WAVE

85
Q
A

WPW

  • can lead to a form of SVT
  • fast: 220-300bmp, regular
  • abrupt onset and termination
  • 1:1 conduction

Treatment: break AV circuit
1. vagal maneuvers, adenosine- transiently block AV node
2. cardioversion, rapid atrial pacing- break the circuit

86
Q

Congenital heart defect MC associated with accessory pathway

A

Ebstein’s

  • displacement of TV disrupts normal barrier of conduction between A and V
tall p waves= RA enlargement, RBBB
87
Q

Atrial flutter

A

CARDIOVERSION FIXES IT!
Heart rate 250-350

Ventricular rate= 300 when 1:1
= 150 when 2:1

88
Q

Mechanism of epinephrine for heart in a code

A

Increases dromotropy (increased conduction velocity)

89
Q

Indomethacin for PDA closure
IV

A

NSAID, nonselective cyclooxygenase inhibitor that blocks prostaglandin synthesis
greater clearance with increasing postnatal age/weight

Successful closure of PDA in 60-80%, 25% relapse

Contraindications: PDA R to L, evolving IVH, NEC, poor renal function, SIP, severe thrombocytopenia

Complications: GI bleed, transient oliguria, incr Cr, hyponatremia (2nd to fluid retention), dec platelet aggregation, dec intestinal perfusion

90
Q

Ibuprofen for PDA closure
IV or PO

A

NSAID, nonselective cyclooxygenase inhibitor that blocks prostaglandin synthesis

Similar efficacy as indomethasin (~70%), 25% relapse

Issues: similar to indomethacin

91
Q

Acetaminophen for PDA closure
IV or PO

A

Decreases prostaglandin synthesis (thought to occur at the peroxidase site of cyclooxygenase)

Similar efficacy (70-80%) (lower if 3-day course)
When used as rescue after failed indomethacin–> ~45% with smaller or closed PDA
Improved efficacy if initiated within 1st week

Issues: less impact on renal function, incr LFTs (avoid if liver disease)

unknown long-term risks

92
Q

Prostaglandin (PGE1)

A

Action: effect within 30 min, maintains PDA patency, most effective if initiated close to birth, vasodilator

Side effects; apnea (< 6 hrs of initiation, related to dose), fever, cutaneous flushing, bradycardia

Chronic effects: cortical bone proliferation

WORSEN clinical status:
1. TAPVR- obstructive
2. HLHS- restrictive/intact atrial septum
3. TGA- restrictive atrial septum
4. Mitral valve atresia with restricted PFO

93
Q

Most common cause of a complete vascular ring

A

Double aortic arch

94
Q

what embryonic week do the endocardial cushions come together to create the intracardiac septa?

A

8th week

cardiogenesis begins at the 5th week- formation of paired heart tubes
heart begins to beat during the 6th week
septation occurs between week 7-8

95
Q

from what embryonic structure does the ductus arteriosus arise?

A

LEFT 6th aortic arch

96
Q

embryonic structures of the heart

A

LEFT 6th aortic arch –> ductus arteriosus
proximal 6th aortic arches –> proximal branch pulmonary arteries
1st/2nd arches –> diseappear then portion of 1st arch –> maxillary artery
3rd arch –> carotid artery
RIGHT 4th arch –> RIGHT subclavian
LEFT 4th arch –> part of aortic arch
5th arch –> involutes
bulbus cordis = primitive heart = conotruncus

97
Q

normal newborn EKG findings

A

right-sided forces
QRS axis initially deviated to the R
upright T waves in V1 –> RV strain
small QRS voltages i limg leads
T waves of low voltage
Abnormal P waves

98
Q

right atrial enlargement on EKG

A

Tall peaked P waves

99
Q

name highest to lowest O2 b/w umbilical and uterine vessels

A

UTERINE artery
UTERINE vein
UMBILICAL vein
UMBILICAL artery

100
Q

QT interval

A

abnormal if > 0.44
can be normal up to 0.46 in females

QTc = QT/square root of R-R interval (sec)

repreasents duration of activation and recovery of the ventricular myocardium

can be caused by hypomagnesemia, hypocalcemia, hypokalemia

Syndromes:
Romano-Ward- AD
Lang-Nielsen- AR, assoc with deafness

Torsades de Pointes- tachycardia, vfib –> tx with magnesium

101
Q

cardiac output

A

HR x SV

102
Q

EKG changes with electrolytes

A
103
Q

cerebral blood flow

A
104
Q

alpha and beta receptors

A
105
Q

sensitivity and specificity for CCHD

A

2003: sensitivity 60%, specificity 99%

low sensitivity for detection of interrupted aortic arch, DORV, Ebstein, coarct

106
Q

how is cardiac output improved?

A
  1. inotropy- increase myocardial contraction with greater shortening fraction
  2. chronotropy- increase HR
  3. lusitropy: increase diastolic filling/increase myocardial relaxation during diastole (milrinone- UNIQUE)
  4. dromotropy: faster electrical conduction of cardiac contraction signals during systole (EPI)
107
Q

benefit of lusitropy (milrinone)

A

negligible effect on myocardial oxygen consumption

108
Q

decreases intracellular calcium to enhance lusitropy (diastolic relaxation)

Phosphodiesterase 3 inhibitor –> decreases cAMP

A

milrinone